메뉴 건너뛰기
PharmacoEconomics
Volumn 16, Issue SUPPL. 2, 1999, Pages 23-28
Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/250μg vs fluticasone propionate 250μg in adults and adolescents with asthma IV: Results
Author keywords

[No Author keywords available]
Indexed keywords

FLUTICASONE PROPIONATE; SALMETEROL;
EID: 0033429906     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916002-00004     Document Type: Article
Times cited : (26)
References (9)
  • 1
    • 0003736036 scopus 로고
    • Global strategy for asthma management and prevention
    • January
    • Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, January 1995
    • (1995) NHLBI/WHO Workshop Report
  • 2
    • 0028264310 scopus 로고
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
    • Allen & Hanburys Limited UK Study Group
    • Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-24
    • (1994) Lancet , vol.344 , pp. 219-224
    • Greening, A.P.1    Ind, P.W.2    Northfield, M.3
  • 3
    • 0029880013 scopus 로고    scopus 로고
    • Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids
    • Woolcock A, Lundbäck B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-8
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 1481-1488
    • Woolcock, A.1    Lundbäck, B.2    Ringdal, N.3
  • 4
    • 1842370350 scopus 로고    scopus 로고
    • Effect of inhaled formoterol and budesonide on exacerbations of asthma
    • Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
    • Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337 (20): 1405-11
    • (1997) N Engl J Med , vol.337 , Issue.20 , pp. 1405-1411
    • Pauwels, R.A.1    Lofdahl, C.G.2    Postma, D.S.3
  • 5
    • 0001115130 scopus 로고    scopus 로고
    • Inhaled fluticasone propionate and salmeterol in moderate adult asthma. I: Lung function and symptoms
    • Ind PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. I: Lung function and symptoms. Am J Respir Crit Care Med 1998; 157: A416
    • (1998) Am J Respir Crit Care Med , vol.157
    • Ind, P.W.1    Dal Negro, R.2    Colman, N.C.3
  • 6
    • 0001115128 scopus 로고    scopus 로고
    • Inhaled fluticasone propionate and salmeterol in moderate adult asthma. II: Exacerbations
    • Ind PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. II: Exacerbations. Am J Respir Crit Care Med 1998; 157: A415
    • (1998) Am J Respir Crit Care Med , vol.157
    • Ind, P.W.1    Dal Negro, R.2    Colman, N.C.3
  • 7
    • 0032906413 scopus 로고    scopus 로고
    • The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
    • Condemi JJ, Goldstein S, Kalberg C, et al. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol 1999; 82 (4): 383-9
    • (1999) Ann Allergy Asthma Immunol , vol.82 , Issue.4 , pp. 383-389
    • Condemi, J.J.1    Goldstein, S.2    Kalberg, C.3
  • 8
    • 0343916895 scopus 로고    scopus 로고
    • The salmeterol xinafoate/fluticasone propionate dry powder combination product via Diskus inhaler improves asthma control compared to the individual products in patients previously treated with inhaled corticosteroids
    • White M, Shapiro G, Taylor J, et al. The salmeterol xinafoate/fluticasone propionate dry powder combination product via Diskus inhaler improves asthma control compared to the individual products in patients previously treated with inhaled corticosteroids. Am J Respir Crit Care Med 1999; 159 (3 Pt 2): A635
    • (1999) Am J Respir Crit Care Med , vol.159 , Issue.3 PT 2
    • White, M.1    Shapiro, G.2    Taylor, J.3
  • 9
    • 17644437848 scopus 로고    scopus 로고
    • Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma. II: Study methodologies
    • Pieters WR, Lundbäck B, Johansson G, et al. Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma. II: Study methodologies. Pharmacoeconomics 1999; 16 Suppl. 2:9-14
    • (1999) Pharmacoeconomics , vol.16 , Issue.SUPPL. 2 , pp. 9-14
    • Pieters, W.R.1    Lundbäck, B.2    Johansson, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.